Home/Filings/4/0000950170-25-035926
4//SEC Filing

Hashad Yehia 4

Accession 0000950170-25-035926

CIK 0001463361other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 8:03 AM ET

Size

5.7 KB

Accession

0000950170-25-035926

Insider Transaction Report

Form 4
Period: 2025-03-08
Hashad Yehia
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-08+20,00020,000 total
    Exercise: $1.68Exp: 2035-03-07Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]Shares subject to the stock option vest and become exercisable in successive, equal monthly installments over a 36-month period commencing on March 8, 2025 (the "Vesting Commencement Date"), so that 100% of the shares become fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file

Issuer

Unity Biotechnology, Inc.

CIK 0001463361

Entity typeother

Related Parties

1
  • filerCIK 0001877701

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 8:03 AM ET
Size
5.7 KB